drugset / Trial / NCT00422994

A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole

NCT00422994

Phase 1 Completed 48 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

This study will investigate the effects of severe renal impairment and hemodialysis on the characteristics of the drug, ropinirole.

Timeline

Start
2006-04
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule